INTRODUCTION
Up to 7-20% of cases of acute cholecystitis (AC) are caused by a common bile duct stone (CBDS). [1] [2] [3] The presence of a CBDS affects the management of AC in terms of timing and type of surgery. The diagnostic workup for a suspected AC case in the Emergency Department (ED), namely gallbladder ultrasounds and possibly abdominal CT scans are not highly sensitive or specific for detecting a CBDS. 4, 5 Delays in definitive disposition and management pathophysiologically have high LFTs. 8 While LFT elevation in AC + may be a direct effect of the obstructing CBDS, in patients with AC -, high LFT values may result from reactive hepatitis, portal tract inflammation, and direct pressure on biliary tract. [9] [10] [11] [12] Abnormal LFTs are more common in AC + than in AC -. 6, 8 Elevated LFTs were previously found to be significantly and independently associated with the presence of CBDS. 13 Another study by Padda et al. 8 found that the LFTs were all abnormal in 53% of AC + as compared to 18% of AC -only, while all LFTs were normal in 35% of patients with AC -and 0.5% of AC + patients. Abnormal LFTs (including g-GT, alkaline phosphatase, ALT, and total bilirubin) were also previously identifed as strong predictors for CBDS. 8, 13 The utility of LFTs in predicting the presence of CBDS was however challenged by several other studies. One study reported that only 42% of the cases with elevated liver enzymes also had a CBDS. 13 Many other studies found limited evidence for the link between LFTs and the presence of a CBDS. [14] [15] [16] One study even suggested that none of the laboratory results were related to the presence of a CBDS. 17 It is worth noting that even studies that found significant correlations between LFTs and the presence of a CBDS found relatively high numbers of false positive and false negative findings 13 questioning their use as predictors for CBDS.
In this study, we aimed to describe characteristics of patients with confirmed acute cholecystitis and assess the utility of LFTs in predicting the presence of a CBDS in a large sample of patients from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database. All statistical analyses were performed using SAS 9.4.
MATERIALS AND METHODS

Setting and study population
Statistical significance was set at a bilateral p-value of 0.05. 
RESULTS
Characteristics of AC patients
Laboratory data
Mean values for LFTs were significantly higher in the 
p＜0.0001).
To assess the clinical utility of examining the three LFTs included in our study as binary variables for the prediction of CBDS in AC patients, ROC curves were constructed and the best cut-off points were determined using There are several mechanisms may be responsible for the false negative and false positive LFTs in AC patients.
In theory, CBD stones cause biliary obstruction with increased intra-biliary pressure due to hindrance of bile flow and subsequent peri-ductal inflammation and hepatocellular injury with elevated LFTs. 8, 10, 25 However, partially obstructing stones may not cause elevated bilirubin levels thus generating false negative values. 7, 13 It is also possible for stones to spontaneously enter or pass from the CBD during the time period between blood sampling and surgery, thereby leading to both false negative or positive results, respectively. 13 The presence of sludge or microlithiasis in the common bile duct could lead to an increased bile viscosity with subsequent elevation in liver function tests whereas they may go undetected on intraoperative cholangiography after they are washed out by the contrast medium to the duodenum, thus increasing the population of AC -patients with abnormal LFTs. 26, 27 Cases of concomitant Sphincter of Oddi dysfunction, 28-31 conjugation defects 32, 33 or Mirizzi syndrome 34 with limited diagnostic value. 13 Other studies have found different liver enzymes such as g-GT as more reliable predictors 7 and Parra Pérez et al. 17 concluded that none of the LFT results were associated with CBD stones. Many other studies targeting the use of LFTs for the prediction of CBDS only had limited results. [14] [15] [16] Although ALP was found to have the most predictive power for a CBD stone, it is not advisable to order it solely as 56.6% of AC + cases would be missed. CBDS should be suspected if any of the predictors is elevated. 13 Increasing the number of ordered LFTs substantially increased DORs for the prediction of a CBDS from 2.23 for any single LFT to 5.73 for any two LFTs up to 12.0 for all three LFTs (Table 4) . Ordering the three LFTs together is advised for recognition of CBDS in AC patients.
For the diagnosis of CBDS, current practice relies on MRCP which is noninvasive or endoscopic ultrasound (EUS) which is less invasive than ERCP. EUS was found to have a sensitivity of 94% and a specificity of 95% in a meta-analysis on 27 studies with 2763 patients. 35 MRCP was found to have a sensitivity of 93% and a specificity of 94% in a review of 13 studies. 36 In our study, individual LFTs were found to have a sensitivity of 47.7 to 62.8% and specificity of 72.9 to 79.8%. Although sensitivity and specificity of gold standard diagnostic procedures remain higher, prediction of CBD stone through basic blood tests can be of great help before radiologic tests. 
